SUBSCRIBE
SUBSCRIBE
News   Business

GenMark Diagnostics Reports Fourth Quarter and Year End 2012 Results

March 13, 2013 | 
1 min read

GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today reported financial results for the fourth quarter and year ended December 31, 2012.

Earnings
MORE ON THIS TOPIC
Sangamo's headquarters in Silicon Valley
Gene therapy
Sangamo’s Stock Plummets as Pfizer Axes Hemophilia Gene Therapy Pact
January 2, 2025
 · 
2 min read
 · 
Nick Paul Taylor
Art collage, hands and falling coins in orange circle. Modern design of finance and business.
Venture Capitalists
To Attract VC Dollars in 2025, Biopharma Must Bring the Data: Pitchbook
December 23, 2024
 · 
2 min read
 · 
Annalee Armstrong
Doubtful businessman stands in front of a crossroad with road split in three different ways as arrows shows opposed courses. Business challenge, choosing a correct pathway. Difficult decision concept
Executive Appointments
After Month of Bad News, Applied Shuffles Leadership, Lays Out Uncertain Path for Rare Disease Drug
December 23, 2024
 · 
2 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Stubborn Layoff Trend Continues Across Biopharma in 2024
December 23, 2024
 · 
207 min read
 · 
BioSpace Editorial Staff